• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

March 20, 2014: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
136th Meeting via Teleconference
Rockwall II, Conference Room 1033
5515 Security Lane, Rockville, MD
March 20, 2014

March 20, 2014: DRAFT AGENDA
Open Session
11:30 a.m. Call to Order and Opening Remarks Robert Daum, M.D., Chair
Conflicts of Interest Statement Prabha Atreya, Ph.D., DFO
Presentation of Laboratory of Respiratory and Special Pathogens, Division of Bacterial, Parasitic and Allergenic Products and Laboratory of Hepatitis Viruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research
11:40 a.m. Overview of Research/Site Visit Process,
Center Biologics Evaluation and Research (CBER)
Carolyn Wilson, Ph.D., FDA
12:10 p.m. Overview Division of Bacterial, Parasitic and Allergenic Products, OVRR Jay Slater, M.D., FDA
12:25 p.m. Overview Laboratory of Respiratory and Special  Pathogens Michael Schmitt, Ph.D., FDA
12:40 p.m. Overview Division of Viral Products Jerry Weir, Ph.D., FDA
12:55 p.m. Overview Laboratory of Hepatitis Viruses  Marian Major, Ph.D., FDA
1:10 p.m. Open Public Hearing (if no speakers, will move directly to closed session)
2:10 p.m. Closed Session
3:20 p.m. Adjourn Meeting